Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders??? Equity

v3.24.1
Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Series A
Preferred Stock
Series B
Preferred Stock
Series C
Preferred Stock
Series D
Preferred Stock
Series E
Preferred Stock
Series F
Preferred Stock
Series F-1
Preferred Stock
Series F-2
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2021 $ 1 $ 82,677 $ (73,690) $ 8,988
Balance (in Shares) at Dec. 31, 2021 251 1,443 500,756           242,808      
Conversion of January Notes into Series F preferred stock in connection with Exchange Agreements                      
Issuance of common stock and warrants, net of fees 855 855
Issuance of common stock and warrants, net of fees (in Shares)                 20,834      
Issuance of common stock warrants in connection with SLOC 223 223
Issuance of Series D preferred stock and warrants, net of fees 1,039 1,039
Issuance of Series D preferred stock and warrants, net of fees (in Shares)       1,058                
Issuance of common stock/At-the-market offering, net of offering costs 1,249 1,249
Issuance of common stock/At-the-market offering, net of offering costs (in Shares)                 56,136      
Issuance of common stock warrants in connection with consideration payable 86 86
Stock-based compensation $ 1 2,404 2,405
Stock-based compensation (in Shares)                 18,255      
Net loss (14,315) (14,315)
Balance at Dec. 31, 2022 $ 2 88,533 (88,005) 530
Balance (in Shares) at Dec. 31, 2022 251 1,443 500,756 1,058         338,033      
Exercise of common stock warrants $ 1 2,061 $ 2,062
Exercise of common stock warrants (in Shares)                 109,257     225,000
Issuance of common stock in connection with conversion of notes 516 $ 516
Issuance of common stock in connection with conversion of notes (in Shares)                 31,466      
Issuance of common stock in connection with equity line of credit   4,489   4,489
Issuance of common stock in connection with equity line of credit (in Shares)                 3,986,991      
Issuance of Series E preferred stock in connection with LOC 4,350 4,350
Deemed dividend for repricing of Series D preferred stock 6 (6)
Commitment to issue shares of common stock in connection with March waiver agreement 298 298
Issuance of common stock in connection with Series A and Series B Dividends
Issuance of common stock in connection with Series A and Series B Dividends (in Shares)                 6,921      
Issuance of common stock upon the conversion of Series E preferred stock $ 1 1
Issuance of common stock upon the conversion of Series E preferred stock (in Shares)                 83,334      
Issuance of common stock in connection with conversion of October Notes $ 1 2,165 2,166
Issuance of common stock in connection with conversion of October Notes (in Shares)                 248,984      
Dividends paid in shares of Series D preferred stock
Dividends paid in shares of Series D preferred stock (in Shares)       139                
Series D preferred stock exchanged for Series F preferred stock in connection with Exchange Agreements (450) (450)
Series D preferred stock exchanged for Series F preferred stock in connection with Exchange Agreements (in Shares)       (1,197)   1,847            
Conversion of Demand Notes and October Notes into Series F preferred stock in connection with Exchange Agreements 1,276 1,276
Conversion of Demand Notes and October Notes into Series F preferred stock in connection with Exchange Agreements (in Shares)           3,198            
Conversion of January Notes into Series F preferred stock in connection with Exchange Agreements 82 82
Conversion of January Notes into Series F preferred stock in connection with Exchange Agreements (in Shares)           206            
Issuance of Series F-1 preferred stock 1,372 1,372
Issuance of Series F-1 preferred stock (in Shares)             3,583          
Issuance of Series F-2 preferred stock 464 464
Issuance of Series F-2 preferred stock (in Shares)               1,153        
Conversion of Series F preferred stock into common stock      
Conversion of Series F preferred stock into common stock (in Shares)           (803)     103,234      
Conversion of Series F-1 preferred stock into common stock      
Conversion of Series F-1 preferred stock into common stock (in Shares)             (2,930)   325,737      
Commitment to issue shares of common stock in connection with January Notes 2,410 2,410
Commitment to issue shares of common stock in connection with LOC Notes 230 230
Commitment to issue shares of Series E preferred stock in connection with LOC Notes 3,363 3,363
Commitment to issue shares of common stock in connection with Demand Notes 286 286
Issuance of common stock to settle commitment shares $ 1 (1)
Issuance of common stock to settle commitment shares (in Shares)                 570,916      
Issuance of common stock in connection with January Notes Settlement 1,160 1,160
Issuance of common stock in connection with January Notes Settlement (in Shares)                 189,602      
Issuance of common stock in connection with equity line of credit 114 114
Issuance of common stock in connection with equity line of credit (in Shares)                 21,841      
Reverse stock split rounding                      
Reverse stock split rounding (in Shares)                 30,709      
Issuance of common stock/At-the-market offering, net of offering costs $ 1 8,227 8,228
Issuance of common stock/At-the-market offering, net of offering costs (in Shares)                 19,658,798      
Stock-based compensation 714 714
Stock-based compensation (in Shares)                 38,335      
Net loss (28,984) (28,984)
Balance at Dec. 31, 2023 $ 7 $ 121,665 $ (116,995) $ 4,677
Balance (in Shares) at Dec. 31, 2023 251 1,443 500,756 0   4,448 653 1,153 25,744,158